900 / 1224
/
/
Dose and fractionation
Increase in G2 but not in G3 toxicity
Matthias Guckenberger - DEGRO 2015
11
13.06.2016
5 x 7Gy, once weekly
pHART3
5 x 8Gy, once weekly
pHART6
Risk
Low risk
Low-intermediate risk
Follow-up
74 mo
36 mo
Median PSA nadir
0.4 ng/ml
0.3 ng/ml
2a bRFS-2+nadir
98.7%
100%
GU G2 tox
5%
24.2%
GI G2 tox
7.6%
26.2%
GU & GI G3 tox
No differencs